Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne L Hotard

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Mbio|February 10, 2012
A critical phenylalanine residue in the respiratory syncytial virus fusion protein cytoplasmic tail mediates assembly of internal viral proteins into viral filaments and particlesFyza Y Shaikh, Reagan G Cox, Aaron W Lifland, et al.
Journal of Virology|October 24, 2014
Identification of residues in the human respiratory syncytial virus fusion protein that modulate fusion activity and pathogenesisAnne L Hotard, Sujin Lee, Michael G Currier, et al.
Journal of Virology|June 10, 2016
A Recombinant Respiratory Syncytial Virus Vaccine Candidate Attenuated by a Low-Fusion F Protein Is Immunogenic and Protective against Challenge in Cotton RatsChristina A Rostad, Christopher C Stobart, Brian E Gilbert, et al.
The Journal of Allergy and Clinical Immunology|May 9, 2016
Respiratory syncytial virus infection activates IL-13-producing group 2 innate lymphoid cells through thymic stromal lymphopoietinMatthew T Stier, Melissa H Bloodworth, Shinji Toki, et al.
Antiviral Research|September 26, 2024
Optimization of Bangladesh and Malaysian genotype recombinant reporter Nipah viruses for in vitro antiviral screening and in vivo disease modelingMichael K Lo, Shilpi Jain, Katherine A Davies, et al.
Nature Communications|December 1, 2017
Structural basis of respiratory syncytial virus subtype-dependent neutralization by an antibody targeting the fusion glycoproteinDaiyin Tian, Michael B Battles, Syed M Moin, et al.
Scientific Reports|March 7, 2017
GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and ParamyxovirusesMichael K Lo, Robert Jordan, Aaron Arvey, et al.
The Journal of Infectious Diseases|February 11, 2020
Griffithsin Inhibits Nipah Virus Entry and Fusion and Can Protect Syrian Golden Hamsters From Lethal Nipah Virus ChallengeMichael K Lo, Jessica R Spengler, Lauren R H Krumpe, et al.
Journal of Virology|October 29, 2020
A Respiratory Syncytial Virus Attachment Gene Variant Associated with More Severe Disease in Infants Decreases Fusion Protein Expression, Which May Facilitate Immune EvasionStacey Human, Anne L Hotard, Christina A Rostad, et al.
Plos Pathogens|May 7, 2016
EGFR Interacts with the Fusion Protein of Respiratory Syncytial Virus Strain 2-20 and Mediates Infection and Mucin ExpressionMichael G Currier, Sujin Lee, Christopher C Stobart, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Mbio|February 10, 2012
A critical phenylalanine residue in the respiratory syncytial virus fusion protein cytoplasmic tail mediates assembly of internal viral proteins into viral filaments and particlesFyza Y Shaikh, Reagan G Cox, Aaron W Lifland, et al.
Journal of Virology|October 24, 2014
Identification of residues in the human respiratory syncytial virus fusion protein that modulate fusion activity and pathogenesisAnne L Hotard, Sujin Lee, Michael G Currier, et al.
Journal of Virology|June 10, 2016
A Recombinant Respiratory Syncytial Virus Vaccine Candidate Attenuated by a Low-Fusion F Protein Is Immunogenic and Protective against Challenge in Cotton RatsChristina A Rostad, Christopher C Stobart, Brian E Gilbert, et al.
The Journal of Allergy and Clinical Immunology|May 9, 2016
Respiratory syncytial virus infection activates IL-13-producing group 2 innate lymphoid cells through thymic stromal lymphopoietinMatthew T Stier, Melissa H Bloodworth, Shinji Toki, et al.
Antiviral Research|September 26, 2024
Optimization of Bangladesh and Malaysian genotype recombinant reporter Nipah viruses for in vitro antiviral screening and in vivo disease modelingMichael K Lo, Shilpi Jain, Katherine A Davies, et al.
Nature Communications|December 1, 2017
Structural basis of respiratory syncytial virus subtype-dependent neutralization by an antibody targeting the fusion glycoproteinDaiyin Tian, Michael B Battles, Syed M Moin, et al.
Scientific Reports|March 7, 2017
GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and ParamyxovirusesMichael K Lo, Robert Jordan, Aaron Arvey, et al.
The Journal of Infectious Diseases|February 11, 2020
Griffithsin Inhibits Nipah Virus Entry and Fusion and Can Protect Syrian Golden Hamsters From Lethal Nipah Virus ChallengeMichael K Lo, Jessica R Spengler, Lauren R H Krumpe, et al.
Journal of Virology|October 29, 2020
A Respiratory Syncytial Virus Attachment Gene Variant Associated with More Severe Disease in Infants Decreases Fusion Protein Expression, Which May Facilitate Immune EvasionStacey Human, Anne L Hotard, Christina A Rostad, et al.
Plos Pathogens|May 7, 2016
EGFR Interacts with the Fusion Protein of Respiratory Syncytial Virus Strain 2-20 and Mediates Infection and Mucin ExpressionMichael G Currier, Sujin Lee, Christopher C Stobart, et al.
Pageof 3